These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin. Moustapha ME, Ehrhardt GJ, Smith CJ, Szajek LP, Eckelman WC, Jurisson SS. Nucl Med Biol; 2006 Jan; 33(1):81-9. PubMed ID: 16459262 [Abstract] [Full Text] [Related]
5. 186Re-liposome labeling using 186Re-SNS/S complexes: in vitro stability, imaging, and biodistribution in rats. Bao A, Goins B, Klipper R, Negrete G, Phillips WT. J Nucl Med; 2003 Dec; 44(12):1992-9. PubMed ID: 14660726 [Abstract] [Full Text] [Related]
6. A critical quantum chemical and experimental study of the potentiality of direct labeling of the CN group with [(99m)Tc(CO)(3)](+) or [(186/188)Re(CO)(3)](+) in CN containing biomolecules. Safi B, Mertens J, Kersemans K, Geerlings P. Nucl Med Biol; 2008 Oct; 35(7):747-53. PubMed ID: 18848659 [Abstract] [Full Text] [Related]
13. Novel procedures for preparing 99mTc(III) complexes with tetradentate/monodentate coordination of varying lipophilicity and adaptation to 188Re analogues. Seifert S, Künstler JU, Schiller E, Pietzsch HJ, Pawelke B, Bergmann R, Spies H. Bioconjug Chem; 2004 Jan; 15(4):856-63. PubMed ID: 15264874 [Abstract] [Full Text] [Related]
14. Simple new method for effective concentration of 188Re solutions from alumina-based 188W-188Re generator. Guhlke S, Beets AL, Oetjen K, Mirzadeh S, Biersack HJ, Knapp FF. J Nucl Med; 2000 Jul; 41(7):1271-8. PubMed ID: 10914921 [Abstract] [Full Text] [Related]
15. Steps toward high specific activity labeling of biomolecules for therapeutic application: preparation of precursor [(188)Re(H(2)O)(3)(CO)(3)](+) and synthesis of tailor-made bifunctional ligand systems. Schibli R, Schwarzbach R, Alberto R, Ortner K, Schmalle H, Dumas C, Egli A, Schubiger PA. Bioconjug Chem; 2002 Jul; 13(4):750-6. PubMed ID: 12121130 [Abstract] [Full Text] [Related]
16. Current use and future potential of organometallic radiopharmaceuticals. Schibli R, Schubiger PA. Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1529-42. PubMed ID: 12397472 [Abstract] [Full Text] [Related]
17. Biokinetic and dosimetric studies of 188Re-hyaluronic acid: a new radiopharmaceutical for treatment of hepatocellular carcinoma. Meléndez-Alafort L, Nadali A, Zangoni E, Banzato A, Rondina M, Rosato A, Mazzi U. Nucl Med Biol; 2009 Aug; 36(6):693-701. PubMed ID: 19647176 [Abstract] [Full Text] [Related]
18. Radiolabelling morpholinos with 188Re tricarbonyl provides improved in vitro and in vivo stability to re-oxidation. He J, Liu C, Vanderheyden JL, Liu G, Dou S, Rusckowski M, Hnatowich DJ. Nucl Med Commun; 2004 Jul; 25(7):731-6. PubMed ID: 15208502 [Abstract] [Full Text] [Related]
20. Use of the Oak Ridge National Laboratory tungsten-188/rhenium-188 generator for preparation of the rhenium-188 HDD/lipiodol complex for trans-arterial liver cancer therapy. Jeong JM, Knapp FF. Semin Nucl Med; 2008 Mar 24; 38(2):S19-29. PubMed ID: 18243839 [Abstract] [Full Text] [Related] Page: [Next] [New Search]